Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

SELL
$65.71 - $74.53 $11,959 - $13,564
-182 Reduced 2.05%
8,708 $603,000
Q4 2022

Feb 15, 2023

SELL
$68.48 - $81.09 $209,480 - $248,054
-3,059 Reduced 25.6%
8,890 $639,000
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $53 - $31,504
-410 Reduced 3.32%
11,949 $849,000
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $142,553 - $157,000
-1,963 Reduced 13.71%
12,359 $951,000
Q1 2022

May 17, 2022

SELL
$61.48 - $73.72 $40,453 - $48,507
-658 Reduced 4.39%
14,322 $1.05 Million
Q4 2021

Jan 31, 2022

BUY
$53.63 - $62.52 $27,565 - $32,135
514 Added 3.55%
14,980 $934,000
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $30,650 - $35,902
518 Added 3.71%
14,466 $855,000
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $61 - $67
1 Added 0.01%
13,948 $932,000
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $8,782 - $9,877
148 Added 1.07%
13,947 $880,000
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $85,859 - $97,294
1,487 Added 12.08%
13,799 $856,000
Q3 2020

Oct 23, 2020

SELL
$57.43 - $63.64 $8,155 - $9,036
-142 Reduced 1.14%
12,312 $742,000
Q2 2020

Aug 17, 2020

BUY
$54.82 - $64.09 $1,699 - $1,986
31 Added 0.25%
12,454 $732,000
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $15,312 - $22,251
-330 Reduced 2.59%
12,423 $692,000
Q4 2019

Jan 31, 2020

SELL
$49.21 - $64.19 $84,985 - $110,856
-1,727 Reduced 11.93%
12,753 $819,000
Q3 2019

Oct 21, 2019

SELL
$42.77 - $50.71 $33,360 - $39,553
-780 Reduced 5.11%
14,480 $734,000
Q2 2019

Jul 11, 2019

BUY
$44.62 - $49.34 $36,588 - $40,458
820 Added 5.68%
15,260 $692,000
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $111,220 - $132,617
-2,465 Reduced 14.58%
14,440 $689,000
Q4 2018

Feb 05, 2019

SELL
$48.76 - $63.23 $18,285 - $23,711
-375 Reduced 2.17%
16,905 $879,000
Q3 2018

Oct 09, 2018

SELL
$55.19 - $62.25 $273,024 - $307,950
-4,947 Reduced 22.26%
17,280 $1.07 Million
Q2 2018

Aug 06, 2018

SELL
$50.53 - $62.98 $801,506 - $998,988
-15,862 Reduced 41.64%
22,227 $1.23 Million
Q1 2018

May 04, 2018

BUY
$59.92 - $68.98 $22,470 - $25,867
375 Added 0.99%
38,089 $2.41 Million
Q4 2017

Jan 29, 2018

SELL
$59.94 - $65.35 $53,946 - $58,814
-900 Reduced 2.33%
37,714 $2.31 Million
Q3 2017

Nov 02, 2017

BUY
$55.23 - $63.74 $2.13 Million - $2.46 Million
38,614
38,614 $2.46 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track One Capital Management, LLC Portfolio

Follow One Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on One Capital Management, LLC with notifications on news.